(Press-News.org)
Save the Date for the 15th World Mitochondria Society Annua Meeting on October 29-31, 2024, at DoubleTree by Hilton Berlin Ku’damm, Berlin, Germany. The WMS is pleased to announce the participation of two distinguished keynote speakers for the Targeting Mitochondria 2024 conference in Berlin this October.
Keynote Speaker of Day 1: Prof. Eric Schon
Professor Eric Schon from Columbia University, USA will deliver a presentation titled "Mitochondria in Alzheimer disease: it's not what you think".
Prof. Schon challenges the conventional understanding of Alzheimer's disease, proposing an innovative hypothesis centered around the role of a different amyloid precursor protein cleavage product, C99. His presentation promises fresh perspectives on Alzheimer's disease as a lipid disorder, offering potential breakthroughs in diagnosis and treatment.
Keynote Speaker of Day 2: Prof. Howy Jacobs
Professor Howy Jacobs from Tampere University, Finland, will discuss the implications of elevated mitochondrial temperature for evolution, development, cell signaling, immunity and pathology.
Talk title: Mitochondria: More Heat Than Light?
"Mitochondria are not just producers of ATP or clearing houses of intermediary metabolism. Here I will trace the history of how mitochondria have come to be regarded as key contributors to cell and organismal physiology, and how recent findings have opened up new chapters in our thinking" stated Prof. Jacobs.
Announced Speakers:
Eric Schon, Columbia University, USA
Howy Jacobs, Tampere University, Finland
Jonathan R. Brestoff, Washington University in St. Louis School of Medicine, USA
Indira Mysorekar, Baylor College of Medicine, USA
Naig Gueguen, CHU Angers, France
Maik Hüttemann, Wayne State University, USA
Sonia Levi, Vita-Salute San Raffaele University, Italy
Egbert Mik, Erasmus MC, The Netherlands
Devika S Manickam, Duquesne University, USA
Stephen Tait, University of Glasgow, United Kingdom
Ana Andreazza, University of Toronto, Canada
Jignesh D. Pandya, Walter Reed Army Institute of Research, USA
Giulia Bertolin, Université de Rennes, France
Naotada Ishihara, Osaka University, Japan
Michael B. Powner, City University of London, United Kingdom
For more information and to stay tuned with the latest updates on Targeting Mitochondria 2024, please visit: www.wms-site.com.
Where to Find WMS?
LinkedIn Page
Facebook Page
Eurekalert Releases
Subscribe to our Newsletter.
END
ABSTRACT CT013
SAN DIEGO ― Combining the KRAS G12C inhibitor adagrasib with the anti-EGFR antibody cetuximab demonstrated promising anti-tumor effects in patients with KRAS G12C-mutated metastatic colorectal cancer (CRC), according to pooled results from the Phase I/II KRYSTAL-1 trial reported by researchers from The University of Texas MD Anderson Cancer Center.
The findings were presented today in a plenary session at the American Association for Cancer Research (AACR) Annual Meeting 2024 by Scott Kopetz, M.D., Ph.D., professor of Gastrointestinal ...
ABSTRACT CT014
SAN DIEGO – The first-in-class PARP1-selective inhibitor saruparib demonstrated encouraging early efficacy and a favorable safety profile in patients with homologous recombination repair (HRR)-deficient breast cancers, according to results from the Phase I/II PETRA trial led by researchers at The University of Texas MD Anderson Cancer Center.
Results from the first-in-human trial were presented today at the American Association for Cancer Research (AACR) Annual Meeting 2024 by Timothy Yap, M.B.B.S., Ph.D., professor ...
LOS ANGELES — Researchers with City of Hope®, one of the largest cancer research and treatment organizations in the United States, will present more than 70 abstracts and sessions on innovative clinical trial results, breakthrough diagnostic techniques and advances in treatment options as well as share their expertise on molecular profiling and the microbiome at the AACR Annual Meeting, which started April 5 and ends April 10 in San Diego.
In addition to City of Hope’s robust data being presented throughout the meeting, John D. Carpten, Ph.D., the Irell & Manella Cancer Center Director’s ...
SAN DIEGO – A combination of the KRASG12C inhibitor adagrasib (Krazati) and the anti-epidermal growth factor receptor (EGFR) antibody cetuximab (Erbitux) showed clinical activity and promising survival outcomes in a cohort of patients with metastatic, heavily pretreated, KRASG12C-mutated colorectal cancer, according to results from the phase I/II KRYSTAL-1 trial presented at the American Association for Cancer Research (AACR) Annual Meeting 2024, held April 5-10.
The study was simultaneously published in Cancer Discovery.
KRASG12C mutations occur in around 4% of colorectal cancers and are associated with a poor prognosis. Drugs targeting KRASG12C, such as adagrasib, have emerged ...
SAN DIEGO – Saruparib, a selective inhibitor of poly-ADP ribose polymerase 1 (PARP1), demonstrated a promising objective response rate and progression-free survival in patients with certain homologous recombination repair (HRR)-deficient breast cancers, according to results from the phase I/II PETRA trial presented at the American Association for Cancer Research (AACR) Annual Meeting 2024, held April 5-10.
Although blocking the enzyme PARP1 may be sufficient to prevent DNA repair in HRR-deficient tumors, all PARP inhibitors currently approved by the ...
SAN DIEGO – An investigational exosome-based liquid biopsy accurately detected 97% of stage 1-2 pancreatic cancers when combined with the biomarker CA 19-9, according to research presented at the American Association for Cancer Research (AACR) Annual Meeting 2024, held April 5-10.
“Pancreatic cancer is one of the most fatal malignancies, in large part because the majority of patients are diagnosed only after the cancer has already metastasized,” said Ajay Goel, PhD, senior author of the study and the chair of the Department of Molecular ...
1. Research groups from NIMS, Seagate Technology, and Tohoku University have made a breakthrough in the field of hard disk drives (HDD) by demonstrating the feasibility of multi-level recording using a three-dimensional magnetic recording medium to store digital information. The research groups have shown that this technology can be used to increase the storage capacity of HDDs, which could lead to more efficient and cost-effective data storage solutions in the future.
2. Data centers are increasingly storing vast amounts of data on hard disk drives (HDDs) that use perpendicular ...
While 3D printing has exploded in popularity, many of the plastic materials these printers use to create objects cannot be easily recycled. While new sustainable materials are emerging for use in 3D printing, they remain difficult to adopt because 3D printer settings need to be adjusted for each material, a process generally done by hand.
To print a new material from scratch, one must typically set up to 100 parameters in software that controls how the printer will extrude the material as it fabricates an object. Commonly ...
The biological brain, especially the human brain, is a desirable computing system that consumes little energy and runs at high efficiency. To build a computing system just as good, many neuromorphic scientists focus on designing hardware components intended to mimic the elusive learning mechanism of the brain. Recently, a research team has approached the goal from a different angle, focusing on measuring information transfer instead. Their method went through biological and simulation experiments and then proved effective in an electronic neuromorphic system. It was published ...
Philadelphia, April 8, 2024 – Researchers from Children’s Hospital of Philadelphia (CHOP) found that teens and young adults with mood disorders, such as depression and bipolar disorder, were 30% less likely to obtain their driver’s license than peers without such disorders. Additionally, those youths with mood disorders experienced a slightly elevated risk of crashing. These findings suggest that these teens and young adults could benefit from guidance on obtaining licensure and accessing training to avoid crashes when they are newly licensed.
The findings were published online today ...
